Skip to main content
. Author manuscript; available in PMC: 2015 Sep 2.
Published in final edited form as: Mol Cancer Ther. 2014 Nov 5;14(1):90–100. doi: 10.1158/1535-7163.MCT-14-0496

Table 1.

IC50’s of cisplatin and LB100 on ovarian cancer cell lines.

Cell Line LB100 (μM) (SD) Cisplatin (μM) (SD)
SK-OV3 10.1 (1.8) 7.6 (1.6)
OVCAR8 5.5 (0.5) 7.2 (2.3)
PEO1-Brca2 Missense 6.2 (1.5) 2.1 (0.4)
PEO1-Brca2 STOP 6.9 (1.0) 2.3 (0.3)
PEO4 5.0 (0.6) 4.3 (1.8)
PEO6 5.1 (0.2) 8.0 (1.9)